Farwell Wildon

Related Filers (1)

Other (1)

144
Monday, 2/12/2024
Filing for proposed sale of securities under Rule 144
Show More

Ownership (15)

4
Wednesday, 2/14/2024
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/26/2024
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/13/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/15/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/13/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/14/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/14/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/4/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/4/2021
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More